QR kód

Residential treatment and medication treatment for opioid use disorder: The role of state Medicaid innovations in advancing the field

Background: Mortality due to opioid use continues to increase; effective strategies to improve access to treatment for opioid use disorder (OUD) are needed. While OUD medications exist, they are used infrequently and often not available in residential addiction treatment settings. CMS provides expan...

Celý popis

Uloženo v:
Hlavní autoři: Peggy L. O'Brien, Maureen T. Stewart, Morgan C. Shields, Mackenzie White, Joel Dubenitz, Judith Dey, Norah Mulvaney-Day
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2022-09-01
Edice:Drug and Alcohol Dependence Reports
Témata:
Residential substance use treatment
Medication for opioid use disorder
Medicaid 1115(a) waiver
Opioid use disorder
Buprenorphine
On-line přístup:http://www.sciencedirect.com/science/article/pii/S2772724622000622
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky